vimarsana.com
Home
Live Updates
Vifor Pharma drives transformation with divestment of non-co
Vifor Pharma drives transformation with divestment of non-co
Vifor Pharma drives transformation with divestment of non-core finished drug manufacturing to CordenPharma
Press release content from Business Wire. The AP news staff was not involved in its creation.
Related Keywords
Luxembourg ,
Fribourg ,
Switzerland ,
Portugal ,
Quettingen ,
Switzerland General ,
Lisbon ,
Lisboa ,
Portuguese ,
Swiss ,
Vifor Pharma ,
Julien Vignot ,
Abbas Hussain ,
Michael Quirmbach ,
Nathalie Ponnier ,
Stephen Houldsworth ,
Swiss Stock Exchange ,
Global Head Corporate Communications ,
Swiss Exchange ,
Contract Development Manufacturing Organization ,
Packaging Services ,
Technology Platforms ,
International Chemical Investors Group ,
Contract Development Manufacturing ,
Vifor Pharma Group ,
Fresenius Medical Care ,
Pharma Group ,
Contract Development ,
Manufacturing Organization ,
Drug Products ,
Chief Executive Officer ,
Current Good Manufacturing Practice ,
Small Molecule ,
Vifor Fresenius Medical Care Renal Pharma ,
Highly Potent ,
Small Molecules ,
Global Head ,
Platform Management ,
Business Wire ,
Business ,
Europe ,